A Study to Evaluate the Efficacy and Safety of Maintenance Ublituximab Following Induction With Efgartigimod Administration in Participants With Myasthenia Gravis (MG)

Abroad (travel likely)RecruitingPHASE2

Conditions

Myasthenia Gravis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

TG Therapeutics Investigational Trial Site, Colorado Springs, Colorado, United States
TG Therapeutics Investigational Trial Site, Clearwater, Florida, United States

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study of Aritinercept in Patients With Generalized Myasthenia Gravis

Myasthenia Gravis, Generalized

Abroad (travel likely)RecruitingPHASE1, PHASE2

Altamonte Springs, United States · Boca Raton, United States

A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE)

Myasthenia Gravis, Generalized

Abroad (travel likely)RecruitingPHASE3

Fayetteville, United States

Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)

Generalized Myasthenia Gravis

Abroad (travel likely)RecruitingPHASE3

Phoenix, United States · Longmont, United States

Rituximab EfFicacy IN MyasthEnia Gravis (REFINE)

Myasthenia Gravis, Generalized

Abroad (travel likely)RecruitingPHASE3

Roma, Italy